Shanghai Junshi Biosciences Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 41.44 | -100% | 0 | 0% |
| P/S |
|
26.9 | 20.2 | 33.16% |
|
|
| P/BV |
|
5.51 | 3.68 | 49.72% |
|
|
| P/FCF |
|
-11.17 | 82.02 | -113.62% |
|
|
| Ev/Ebitda |
|
-12.44 | 16.62 | -174.83% |
|
|
| Ev/S |
|
19.47 | 25.64 | -24.09% |
|
|
| Ev/FCF |
|
-9.63 | 85.08 | -111.32% |
|
|
| E/P |
|
-0.0672 | 0.0217 | -409.98% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-161.83 | 6.32 | -2659.7% | -14724.6 | -98.9% |
| ROE |
|
-27.37 | 6.65 | -511.43% |
|
|
| ROA |
|
-19.06 | 3.59 | -631.55% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-151.85 | -76.75 | 97.86% |
|
|
| ROCE |
|
0 | 19.43 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5915 | 0.7406 | -179.87% | -0.6759 | -12.49% |
| Nеt Debt/Ebitda |
|
0 | -0.1122 | -100% |
|
|
| Debt/Ratio |
|
0.1223 | 0.1008 | 21.33% |
|
|
| Debt/Equity |
|
0.1931 | 0.212 | -8.92% |
|
|
| Debt/Net Income |
|
-0.6092 | 1.37 | -144.33% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.3991 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1 | -100% | ||
| DSI |
|
0 | 0.6935 | -100% |
|
|
| Average dividend growth |
|
0 | 3.04 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.4 | -100% |
|
|
| Average percentage for payments |
|
0 | 45.07 | -100% |
|
|
| Difference from average difference in sector |
|
-0.3991 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
9/10
|
93.86 | 23.95 | 291.9% | ||
| Growth impulse Ebitda in 5 years |
|
243.71 | 12.85 | 1796.58% | ||
| Growth impulse Net Income in 5 years |
|
206.7 | 62.77 | 229.3% | ||
| Growth impulse FCF in 5 years |
|
48.11 | 30.35 | 58.52% | ||
| Growth impulse EPS in 5 years |
|
143.99 | 82.9 | 73.69% |
IP Score
4.48/10
